William T. Mckee's Insider Trades & SAST Disclosures

William T. Mckee's most recent trade in Assertio Holdings Inc was a trade of 81,225 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 7, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Assertio Holdings Inc
William T. Mckee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2025 81,225 81,225 - - Stock Option (right to buy)
Assertio Holdings Inc
William T. Mckee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2025 53,750 346,280 (0%) 0% 0 Common Stock
Assertio Holdings Inc
William T. Mckee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 81,225 81,225 - - Stock Option (right to buy)
Assertio Holdings Inc
William T. Mckee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 53,750 292,530 (0%) 0% 0 Common Stock
Assertio Holdings Inc
William T. Mckee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 31,194 260,780 (0%) 0% 0 Common Stock
Assertio Holdings Inc
William T. Mckee Director Sale of securities on an exchange or to another person at price $ 3.14 per share. 10 May 2023 22,000 238,780 (0%) 0% 3.1 69,045 Common Stock
Assertio Holdings Inc
William T. Mckee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 3,821 3,821 - - Stock Option (right to buy)
Assertio Holdings Inc
William T. Mckee Director Sale of securities on an exchange or to another person at price $ 2.35 per share. 12 May 2022 22,322 229,586 (0%) 0% 2.4 52,488 Common Stock
Rein Therapeutics Inc.
William T. Mckee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 96,000 96,000 - - Stock Option (right to buy)
Assertio Holdings Inc
William T. Mckee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 357,143 662,489 (0%) 0% 0 Common Stock
C4 Therapeutics Inc
William T. Mckee Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 19.00 per share. 06 Oct 2020 5,263 5,263 - 19 99,997 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades